|
|
|
|
|
|
By Tiago Aguiar | Picking which phase to introduce automation has serious implications, and the calculation is unique for every product. Here are some important considerations. | |
|
|
|
| Vial Containment Systems For Gene Therapies: Recovery Of Viral Vectors | Article | By Margaret A. Craig, Rui Li, Ph.D., and T. Page McAndrew, Ph.D., West Pharmaceutical Services, Inc. | Vial containment systems were evaluated for maintenance of virus transducability after storage at ultralow temperature. All vectors showed equivalent or better function compared to standard systems. |
|
|
|
| High-Throughput Lipid Separation For LNP Formulations | Application Note | KNAUER | Lipid nanoparticles (LNPs) carry immense potential as delivery systems. Learn about the development of isocratic and gradient methods for high-throughput separation of lipids used in LNP formulations. |
|
|
| Minimizing Residue Build-Up In Cleanrooms | Article | Ecolab Life Sciences | Residues from cleaning agents can pose significant risks to cleanroom operations. Learn about residue management, measurement techniques, and best practices to ensure compliance and product safety. |
|
|
|
| Expanding The Cell And Gene Therapy Manufacturing Workflow | Case Study | Thermo Fisher Scientific Cell And Gene Therapy | A university's training lab overcame operational challenges and create efficiencies in cell and gene therapy manufacturing to bolster its hands-on education for academics, industry researchers, and regulators. |
|
|
| Highly Efficient Production Of Adeno-Associated Virus | Application Note | By Yulong Hong, Lori E. Romeo, Ann M. Ferrie, Vasiliy N. Goral, and Jennifer L. Weber, Corning Life Sciences | This study evaluates the performance of a flexible, automated fixed bed reactor (FBR) system during AAV production, comparing it with a similar FBR system and 2D cell culture controls. |
|
|
|
| High-Titer rAAV Production In Bioreactors Using Producer Cell Lines | Poster | By J. Coronel, A. Al-Dali, A. Patil, K. Srinivasan, T. Braß, K. Hein, and S. Wissing, Cytiva | Here, we detail the upstream process development and optimization for an AAV8-GFP proof-of-concept (PoC) producer single cell clone (SCC) in both batch and perfusion modes. |
|
|
| A Smart Path For Novel Biologics | Article | By Pawel Linke and Markus Neubauer, Roche CustomBiotech | Learn about a solution for streamlining workflow in novel biologics while collecting quality data, by combining single-use microbioreactors with advanced automation and analytical platforms. |
|
|
|
|
| Webinar: How To Optimize Your Advanced Therapy Manufacturing Process Before You Automate | In the biopharmaceutical sector transformative therapies for rare or ultra-rare diseases and curative medicines are seen as extremely risky for investors and developers. Learn how phase-appropriate tools and strategic collaboration can reduce costs, improve scalability, and avoid locking in inefficient processes—without major capital investment. Topics include cryopreservation, separation, and scalable solutions from RUO to cGMP. Click here to learn more. |
|
|
|
|
|
|
|
|
|
Connect With Cell & Gene: |
|
|
|